Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-23-013073
Filing Date
2023-04-20
Accepted
2023-04-20 16:05:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 100324
  Complete submission text file 0001493152-23-013073.txt   101924
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 23833128
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 35TH FLOOR NEW YORK NY 10022 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

EIN.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G